{"nct_id":"NCT01578785","title":"An Efficacy, Safety and Tolerability Study of Glatiramer Acetate (GA) 20 mg/0.5 ml New Formulation Administered Daily by Subcutaneous (SC) Injection in Subjects With Relapsing-Remitting Multiple Sclerosis (RRMS)","status":"TERMINATED","status_verified_date":"2014-02","start_date":"2012-03","start_date_type":null,"primary_completion_date":"2012-10","primary_completion_date_type":"ACTUAL","completion_date":"2012-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}